Occidental's Debt Nears Target, But Buybacks Remain the Missing Catalyst

What happened

Occidental Petroleum has reduced principal debt to $11.8 billion as of late August 2026, nearing its $10 billion target and surpassing the $15 billion reported in early March 2026. This follows the OxyChem divestiture and aggressive liability management, including tender offers and covenant removals, strengthening balance sheet flexibility. Management now projects sustainable $4 billion annual cash flow by 2030 with resilience at $50–$65 WTI, supporting a 2% dividend yield that is expected to grow. However, cash flow remains commodity-sensitive, and tail risks persist from retained OxyChem liabilities and the October 2026 put option on the Zero Coupons. The market is pricing in successful deleveraging, but buybacks—the key catalyst for equity re-rating—have not yet restarted, leaving returns dependent on dividend growth and oil prices.

Implication

The lower debt and projected $4 billion annual cash flow strengthen OXY's ability to sustain and grow its dividend, which currently yields around 2% and is set to increase. However, the company has not yet restarted share repurchases, which were effectively zero in 2025, and that remains the key catalyst for equity re-rating beyond a yield story. If oil prices hold in the $60–$65 range, free cash flow should comfortably cover the dividend and allow for incremental debt reduction, but at $50 WTI, flexibility tightens. Investors should monitor the October 2026 put option on the Zero Coupons ($401 million) and any developments in retained OxyChem liabilities, which could divert cash. Given the stock's recent run to the mid-$50s, the risk-reward is more balanced than earlier in 2026; adding on weakness near $48–$50 makes sense, while trimming above $62 is prudent.

Thesis delta

Debt reduction has outpaced expectations, with principal debt falling to $11.8 billion from $15.0 billion in early March 2026, accelerating the balance-sheet de-risking thesis. The addition of a $4 billion sustainable cash flow projection by 2030 provides a longer-term anchor for dividend growth and potential buybacks, but near-term capital returns remain unproven. The original thesis required buybacks to restart within 6–12 months; this has not yet occurred, so the balance-sheet improvement is positive but not sufficient to upgrade the call.